.jpg)
MOST POPULAR
- Man-made reasons for Uttarakhand disaster 1
- Dhari Devi idol goes missing 2
- Pedestrian questions 14
- Transition failure 1
- Rains over past three days extreme weather event: scientists 1
- Where all did extreme events cause disasters last decade
- Gujarat pollution board gets a makeover in efficiency 33
- Monsoon arrives early; kills over 30 people in Uttarakhand
- Rush of hydropower projects on Ganga, tributaries
- Ahmedabad’s beat-the-heat plan
- Don’t just cash in on tigers 18
- Pedestrian questions 14
- Weather dice is loaded 13
- Odisha's waterman 6
- Is Ganga losing its resilience? 4
- Banking on mothers 3
- Dhari Devi idol goes missing 2
- Court upholds Soliga tribe’s community forest rights 2
- Almost half of doctors in US from lower-income countries 2
- Hills of greyville 1
FOLLOW US ON
A treatment for AIDS
0 Comments
Jan 31, 1998 | From the print edition
The US recognises an Ayurvedic treatment that can help combat AIDS
Surendra Rohtagi, a Kanpur-based medical expert, is on the verge of a breakthrough for a treatment for the acquired immunodeficiency syndrome (AIDS). The fight against the dreaded human immunodeficiency virus (HIV) has received a shot in the arm, thanks to this Indian doctor. Rohtagi was recently granted a patent for his new drug for treating AIDS by the US Patent and Trade Office.
The drug consists of two multi-component Ayurvedic drugs -- Livzon and Imminex -- in predetermined proportions. It works by enhancing the patient's immunity by selective use of herbal drugs, simultaneously stimulating the body's physiological functions.
With the correction of immunodeficiency by the new therapy, the body's own defensive forces selectively kill the infecting germs and the AIDS symptoms disappear in the patient. The drug can be administered in several forms: aqueous extracts, hard gelatine capsules, or mixed in syrup. According to Rohtagi, one advantage of this new treatment is the absence of adverse drug reactions that usually accompany the therapies currently employed.
